抗苗勒管激素对不同年龄妇女生育功能的评估价值分析

摘要

目的 探讨抗苗勒管激素 (AMH) 对不同年龄妇女生育功能的评估价值.方法 选取2016年1月～2017年6月于我院产科门诊行正常孕前检查的妇女240例患者为研究对象, 根据患者年龄将其分为A组18～30岁、B组31～40岁及C组40～45岁, 每组分别为80例.检测三组患者AMH、卵泡刺激素 (FSH) 、黄体生成素 (LH) 及雌二醇 (E2) 含量, 分析其生育能力, 并作统计学分析.结果 C组妇女血清AMH含量 (2.07±1.28) ng/mL显著低于A、B组, 差异有统计学意义 (P 0.05) ;C组AMH 0.05).The cases of AMH < 1.1 ng/mL in group C was significantly more than that in group B and group A, and the difference was statistically significant (P < 0.05).The incidence of infertility in women with AMH < 1.1 ng/mL was 78.85％, significantly higher than that in women with AMH ≥ 1.1 ng/mL (21.15％), and the difference was statistically significant (P < 0.05).Conclusion AMH can be used to evaluate ovarian and reproductive function in women of childbearing age.AMH testing before pregnancy can promote the formulation of reasonable birth planning and achieve aristogenesis goals.